Credit Suisse’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,411
Closed -$73.2K 3115
2023
Q3
$73.2K Sell
2,411
-128
-5% -$6.17K ﹤0.01% 3109
2023
Q2
$161K Buy
2,539
+632
+33% +$54.2K ﹤0.01% 3114
2023
Q1
$289K Buy
1,907
+178
+10% +$36.1K ﹤0.01% 3005
2022
Q4
$493K Buy
1,729
+1,723
+28,717% +$331K ﹤0.01% 2785
2022
Q3
$1K Buy
+6
New +$2.54K ﹤0.01% 3888

Other funds holding NUTX

Credit Suisse's NUTX Position: Q4 2023 in Review

Credit Suisse sold out of Nutex Health (NUTX) in Q4 2023, closing a stake of 2,411 shares — an estimated $73.2K sold.

Credit Suisse first reported a position in NUTX in Q3 2022 and held it in 5 quarters. The position peaked at $493K in Q4 2022. 49 funds tracked by Wall St. Rank hold NUTX as of Q4 2023.

  • Credit Suisse reported no remaining Nutex Health position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 2,411 Nutex Health shares in Q4 2023, an estimated $73.2K.
  • Credit Suisse first reported a position in Nutex Health in Q3 2022 and held it in 5 quarters.
  • Credit Suisse's Nutex Health position peaked at $493K in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Nutex Health as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.